Robert E. Landry

2018

In 2018, Robert E. Landry earned a total compensation of $9.4M as Senior Vice President, Finance and Chief Financial Officer at Regeneron Pharmaceuticals, a 95% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$581,400
Option Awards$3,308,184
Salary$680,000
Stock Awards$4,767,500
Other$19,535
Total$9,356,619

Landry received $4.8M in stock awards, accounting for 51% of the total pay in 2018.

Landry also received $581.4K in non-equity incentive plan, $3.3M in option awards, $680K in salary and $19.5K in other compensation.

Rankings

In 2018, Robert E. Landry's compensation ranked 772nd out of 14,244 executives tracked by ExecPay. In other words, Landry earned more than 94.6% of executives.

ClassificationRankingPercentile
All
772
out of 14,244
95th
Division
Manufacturing
254
out of 5,758
96th
Major group
Chemicals And Allied Products
74
out of 2,119
97th
Industry group
Drugs
57
out of 1,808
97th
Industry
Pharmaceutical Preparations
39
out of 1,382
97th
Source: SEC filing on April 26, 2019.

Landry's colleagues

We found four more compensation records of executives who worked with Robert E. Landry at Regeneron Pharmaceuticals in 2018.

2018

Leonard Schleifer

Regeneron Pharmaceuticals

Chief Executive Officer

2018

George Yancopoulos

Regeneron Pharmaceuticals

Chief Scientific Officer

2018

Marion McCourt

Regeneron Pharmaceuticals

Senior Vice President, Commercial

2018

Daniel Van Plew

Regeneron Pharmaceuticals

Executive Vice President and General Manager, Industrial Operations and Product Supply

News

You may also like